TNFRSF18 and cancer: GITR, a TNF superfamily receptor, is highly expressed on tumor-infiltrating regulatory T-cells and has been used as a target to deplete regulatory T-cells in the tumor by ADCC to enhance the efficacy of cancer immunotherapy37.